AllianzIM to Transfer Exchange Listings and Fund Name Changes

Allianz Investment Management LLC (AllianzIM), a subsidiary of Allianz Life Insurance Company of North America, has announced that it will transfer the listing exchange for its Buffered Exchange-Traded Funds (ETFs) from NYSE Arca to Cboe BZX Exchange, effective around December 22, 2025. Alongside this change, AllianzIM will also update the naming convention for its U.S. Large Cap Buffer10 and Buffer20 products, focusing on simplifying fund names to a more straightforward "U.S. Equity Buffer" format.

The transition affects 30 ETFs, which will now feature the new naming structure while maintaining their existing investment strategies and management teams. Current shareholders need not take any action; the funds’ investment objectives and strategies remain unchanged, ensuring continuity for investors.

AllianzIM's Buffered Outcome ETFs are designed to mitigate risk and lower volatility while allowing investors to benefit from the equity markets up to a specified cap with a defined downside buffer. This dual approach provides a unique investment opportunity, emphasizing the importance of understanding the associated strategies and risks involved, as these products may not be suitable for all investors.

Additionally, four specific funds will also transition to the Cboe BZX Exchange as part of this update, reinforcing AllianzIM's commitment to delivering innovative investment solutions. Prospective investors are encouraged to carefully review the prospectus before committing to any investments, noting that all investment carries inherent risks, including potential loss of principal.

For more information about AllianzIM's Buffered ETF product lineup and for further educational resources, investors can visit the AllianzIM website. This strategic move underlines AllianzIM's ongoing dedication to risk management and innovative financial solutions.

Allianz Investment Management LLC (AllianzIM) has recently announced the transfer of its Buffered ETFs' primary listing exchange from NYSE Arca to Cboe BZX Exchange, effective December 22, 2025. This strategic move is expected to enhance liquidity and trading efficiency for investors. Cboe BZX is known for its robust trading platforms and may offer lower trading costs, which can potentially benefit ETF investors.

In conjunction with the exchange change, AllianzIM is also implementing fund name changes for 30 of its ETFs. The transition from "Large Cap Buffer" to "Equity Buffer" in the fund names reflects a broader investment strategy focused on U.S. equities while maintaining the risk mitigation strategies that define these products. Current shareholders will not need to take any action, ensuring a smooth transition without disrupting their investment experience.

For investors considering these ETFs, it is crucial to understand their core objectives: providing exposure to equity markets while limiting downside risk through explicit buffers. This hybrid approach may appeal to conservative investors seeking growth potential with downside protection. However, as these funds are not typical investment products, assessing individual risk tolerance and investment goals is essential.

Before acting on this information, potential investors should review the updated prospectus due to the ongoing changes. The prospectus will detail the investment strategy, risks, and charges associated with these funds. Given the complexities involved with buffered ETFs and the volatility they may experience, it is advisable to consult with a financial advisor to determine suitability for your investment portfolio.

In summary, AllianzIM’s strategic changes position it for improved market performance while continuing to prioritize investor protection. This transition could offer an opportunity for investors seeking innovative solutions to navigate current market conditions.